December 2019

The ground-breaking ceremony was held on Wednesday in the presence of Marianne Reichelt, Mayor of Neuhaus am Rennweg, and Christine Zitzmann, District Administrator of Sonneberg rural district council. In making this investment, the international Röchling Group, to which HPT has belonged since the beginning of 2015, is continuing its strategic expansion in pharmaceutical and medical technology and safeguarding long-term growth at the site in Thuringia.

DuraSense is a blend of wood fibres and polymers, which can be fossil, bio-based or recycled. With DuraSense, Stora Enso offers customers a more eco-friendly alternative to plastics while improving sustainability performance and reducing carbon footprint. With the blend of wood fibres and bio-based polymers, it is possible to get up to 98% renewable content and, thus, reduce the dependency on limited fossil resources.

Im Rahmen einer großen Gala in Würzburg wurden im Beisein von Persönlichkeiten aus Politik, Wirtschaft und Medien die Finalisten und Preisträger des renommierten Wettbewerbs geehrt.

Sympfiny® consists of a container for storage and an accurately fitting oral syringe for the drawing and administration of the multi-particulate drug. The oral syringe will be connected to the container and the drug is then precisely dosed, drawn and administered. A plastic part sets the dosage in a safely and transparent way. This easy handling allows to administer the multi-particulate drugs as intuitively and safely as liquid drugs. With the oral syringe, the users can rely on a trusted and proven system that is standard with liquid drugs.

Since the company’s founding, the number of employees has more than quadrupled
Neuhaus am Rennweg – Röchling-HPT of Neuhaus am Rennweg, Germany, is celebrating its 15th birthday. As the producer of primary packaging for the pharmaceutical and diagnostics industries reaches this milestone, the signs point to continued growth: In the run-up to 2023, the site will be gradually expanded and 50 new jobs created.

With Dr. Carl Peter Thürmel, Vice-chairman of the Advisory Board of the Röchling Group in attendance, the new building was ceremoniously opened by Röchling Group and Medical division CEO Professor Hanns-Peter Knaebel, who transferred the building to Joachim Lehmann, BU Director Medical Europe, and to Alexander Stauch, Managing Director BU Medical Europe.